Arena Pharma links with Ildong for Belviq marketing in South Korea


USA-based Arena Pharmaceuticals (Nasdaq: ARNA) has entered into a marketing and supply agreement with…

Arena PharmaceuticalsAsia-PacificBelviqIldong PharmaLicensingMarkets & MarketingMetabolicsPharmaceutical

AstraZeneca drops early-stage obesity drug; Roche loses out on Indian Tarceva dispute


Anglo-Swedish drug major AstraZeneca (LSE: AZN) has told its development partner Palatin Technologies…

Asia-PacificAstraZenecaCiplaErlocipGenericsMetabolicsOncologyPalatin TechnologiesPatentsPharmaceuticalResearchRocheTarceva

CASiGEN Pharma created in Hong Kong to bring new potential diabetes treatments to global market


USA-based Ventac Partners and the Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences…

Asia-PacificCASiGEN PharmaDiabetesMarkets & MarketingMetabolicsPharmaceuticalResearch

Indian Health Ministry bans obesity drug rimonabant following reports of side effects; TB drug curb moves “a failure”


After almost 10 months since India’s Drugs Technical Advisory Board (DTAB) recommended its prohibition…

Antibiotics and Infectious diseasesAsia-PacificAventis PharmaBenadrylDexfenfluramineDiphenhydramineGeneralMetabolicsPharmaceuticalReduxRegulationSanofi-Aventis

Back to top